Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 1
1986 1
1990 1
1991 1
1993 2
1997 1
1998 3
1999 1
2000 1
2003 1
2004 1
2005 1
2006 1
2008 2
2009 1
2010 1
2012 1
2013 1
2014 3
2015 2
2016 6
2017 3
2018 6
2019 10
2020 10
2021 12
2022 10
2023 6
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

86 results

Results by year

Filters applied: . Clear all
Your search was processed without automatic term mapping because it retrieved zero results.
Page 1
Distribución espacial de las hospitalizaciones por enfermedad isquémica del corazón en Chile: 2002-2020.
Cárdenas-Pizarro J, Gómez-Varas J, Maturana-Miranda F, Fuenzalida-Díaz M. Cárdenas-Pizarro J, et al. Salud Publica Mex. 2023 Jul 15;65(4, jul-ago):325-333. doi: 10.21149/14575. Salud Publica Mex. 2023. PMID: 38060900 Spanish.
Las tasas maximas determinadas corresponden a 638 por cada 100 000 habs. para sexo masculino y 364 por cada 100 000 habs. para sexo femenino. Las Comunas registran valores de I de Moran para hombres que tienden a dispersarse a medida que avanza el periodo analizado …
Las tasas maximas determinadas corresponden a 638 por cada 100 000 habs. para sexo masculino y 364 por cada 100 000 habs. para sexo femenino …
Stroke genetics informs drug discovery and risk prediction across ancestries.
Mishra A, Malik R, Hachiya T, Jürgenson T, Namba S, Posner DC, Kamanu FK, Koido M, Le Grand Q, Shi M, He Y, Georgakis MK, Caro I, Krebs K, Liaw YC, Vaura FC, Lin K, Winsvold BS, Srinivasasainagendra V, Parodi L, Bae HJ, Chauhan G, Chong MR, Tomppo L, Akinyemi R, Roshchupkin GV, Habib N, Jee YH, Thomassen JQ, Abedi V, Cárcel-Márquez J, Nygaard M, Leonard HL, Yang C, Yonova-Doing E, Knol MJ, Lewis AJ, Judy RL, Ago T, Amouyel P, Armstrong ND, Bakker MK, Bartz TM, Bennett DA, Bis JC, Bordes C, Børte S, Cain A, Ridker PM, Cho K, Chen Z, Cruchaga C, Cole JW, de Jager PL, de Cid R, Endres M, Ferreira LE, Geerlings MI, Gasca NC, Gudnason V, Hata J, He J, Heath AK, Ho YL, Havulinna AS, Hopewell JC, Hyacinth HI, Inouye M, Jacob MA, Jeon CE, Jern C, Kamouchi M, Keene KL, Kitazono T, Kittner SJ, Konuma T, Kumar A, Lacaze P, Launer LJ, Lee KJ, Lepik K, Li J, Li L, Manichaikul A, Markus HS, Marston NA, Meitinger T, Mitchell BD, Montellano FA, Morisaki T, Mosley TH, Nalls MA, Nordestgaard BG, O'Donnell MJ, Okada Y, Onland-Moret NC, Ovbiagele B, Peters A, Psaty BM, Rich SS, Rosand J, Sabatine MS, Sacco RL, Saleheen D, Sandset EC, Salomaa V, Sargurupremraj M, Sasaki M, Satizabal CL, Schmidt CO, Sh… See abstract for full author list ➔ Mishra A, et al. Nature. 2022 Nov;611(7934):115-123. doi: 10.1038/s41586-022-05165-3. Epub 2022 Sep 30. Nature. 2022. PMID: 36180795 Free PMC article.
Two Phase 3 Trials of Gantenerumab in Early Alzheimer's Disease.
Bateman RJ, Smith J, Donohue MC, Delmar P, Abbas R, Salloway S, Wojtowicz J, Blennow K, Bittner T, Black SE, Klein G, Boada M, Grimmer T, Tamaoka A, Perry RJ, Turner RS, Watson D, Woodward M, Thanasopoulou A, Lane C, Baudler M, Fox NC, Cummings JL, Fontoura P, Doody RS; GRADUATE I and II Investigators and the Gantenerumab Study Group. Bateman RJ, et al. N Engl J Med. 2023 Nov 16;389(20):1862-1876. doi: 10.1056/NEJMoa2304430. N Engl J Med. 2023. PMID: 37966285 Clinical Trial.
Making habitat connectivity a reality.
Keeley ATH, Basson G, Cameron DR, Heller NE, Huber PR, Schloss CA, Thorne JH, Merenlender AM. Keeley ATH, et al. Conserv Biol. 2018 Dec;32(6):1221-1232. doi: 10.1111/cobi.13158. Epub 2018 Sep 13. Conserv Biol. 2018. PMID: 29920775 Review.
Efficacy and Safety of NVX-CoV2373 in Adults in the United States and Mexico.
Dunkle LM, Kotloff KL, Gay CL, Áñez G, Adelglass JM, Barrat Hernández AQ, Harper WL, Duncanson DM, McArthur MA, Florescu DF, McClelland RS, Garcia-Fragoso V, Riesenberg RA, Musante DB, Fried DL, Safirstein BE, McKenzie M, Jeanfreau RJ, Kingsley JK, Henderson JA, Lane DC, Ruíz-Palacios GM, Corey L, Neuzil KM, Coombs RW, Greninger AL, Hutter J, Ake JA, Smith K, Woo W, Cho I, Glenn GM, Dubovsky F; 2019nCoV-301 Study Group. Dunkle LM, et al. N Engl J Med. 2022 Feb 10;386(6):531-543. doi: 10.1056/NEJMoa2116185. Epub 2021 Dec 15. N Engl J Med. 2022. PMID: 34910859 Free PMC article. Clinical Trial.
Early Treatment for Covid-19 with SARS-CoV-2 Neutralizing Antibody Sotrovimab.
Gupta A, Gonzalez-Rojas Y, Juarez E, Crespo Casal M, Moya J, Falci DR, Sarkis E, Solis J, Zheng H, Scott N, Cathcart AL, Hebner CM, Sager J, Mogalian E, Tipple C, Peppercorn A, Alexander E, Pang PS, Free A, Brinson C, Aldinger M, Shapiro AE; COMET-ICE Investigators. Gupta A, et al. N Engl J Med. 2021 Nov 18;385(21):1941-1950. doi: 10.1056/NEJMoa2107934. Epub 2021 Oct 27. N Engl J Med. 2021. PMID: 34706189 Clinical Trial.
[RS3PE: A presentation of a case].
Alba Gago I, Vicente López O, Pérez Alonso-Castrillo M. Alba Gago I, et al. Aten Primaria. 2021 Mar;53(3):101978. doi: 10.1016/j.aprim.2021.101978. Epub 2021 Feb 12. Aten Primaria. 2021. PMID: 33588270 Free PMC article. Spanish. No abstract available.
Initial experience with hysteroscopic tubal occlusion (Essure®).
Depes Dde B, Pereira AM, Lippi UG, Martins JA, Lopes RG. Depes Dde B, et al. Einstein (Sao Paulo). 2016 Apr-Jun;14(2):130-4. doi: 10.1590/S1679-45082016AO3717. Einstein (Sao Paulo). 2016. PMID: 27462885 Free PMC article.
Ocorreu um caso de reflexo vagal e 89,5% das pacientes retornaram as atividades normais no mesmo dia. Apos 3 meses, 89,5% das pacientes encontravam-se muito satisfeitas com o metodo. A radiografia simples da pelve evidenciou 92,1% de dispositivos topicos, oco …
Ocorreu um caso de reflexo vagal e 89,5% das pacientes retornaram as atividades normais no mesmo dia. Apos 3 meses, 89,5% das …
A case of non-necrotising herpetic retinitis.
Arenas-Canchuja F, Campos-Dávila B, Valderrama-Albino V. Arenas-Canchuja F, et al. Arch Soc Esp Oftalmol (Engl Ed). 2021 Feb 18:S0365-6691(21)00033-2. doi: 10.1016/j.oftal.2020.12.019. Online ahead of print. Arch Soc Esp Oftalmol (Engl Ed). 2021. PMID: 33612363 English, Spanish.
86 results